Details for Patent: 10,039,779
✉ Email this page to a colleague
Which drugs does patent 10,039,779 protect, and when does it expire?
Patent 10,039,779 protects HARVONI and is included in one NDA.
Protection for HARVONI has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-four patent family members in thirty-four countries.
Summary for Patent: 10,039,779
Title: | Combination formulation of two antiviral compounds |
Abstract: | Disclosed are pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir. |
Inventor(s): | Chal; Ben (Millbrae, CA), Mogalian; Erik (San Francisco, CA), Oliyai; Reza (Burlingame, CA), Pakdaman; Rowchanak (San Carlos, CA), Stefanidis; Dimitrios (Mountain View, CA), Zia; Vahid (San Carlos, CA) |
Assignee: | Gilead Pharmasset LLC (Foster City, CA) |
Application Number: | 15/393,847 |
Patent Claim Types: see list of patent claims | Use; Compound; Dosage form; |
Drugs Protected by US Patent 10,039,779
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences Inc | HARVONI | ledipasvir; sofosbuvir | TABLET;ORAL | 205834-002 | Aug 28, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Gilead Sciences Inc | HARVONI | ledipasvir; sofosbuvir | TABLET;ORAL | 205834-001 | Oct 10, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,039,779
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 095131 | ⤷ Try a Trial | |||
Australia | 2014202687 | ⤷ Try a Trial | |||
Australia | 2015202842 | ⤷ Try a Trial | |||
Australia | 2016216641 | ⤷ Try a Trial | |||
Australia | 2018203696 | ⤷ Try a Trial | |||
Brazil | 112014011938 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |